When the absence of an interaction can become clinically relevant

被引:1
|
作者
Cattaneo, Dario [1 ,2 ]
Bernacchia, Dario [3 ]
Beltrami, Martina [3 ]
Resnati, Chiara [2 ]
Meraviglia, Paola [3 ]
Gervasoni, Cristina [1 ,3 ]
机构
[1] ASST Fatebenefratelli Sacco Univ Hosp, Gest Ambulatoriale Politerapie GAP Outpatient Cli, Milan, Italy
[2] ASST Fatebenefratelli Sacco Univ Hosp, Clin Pharmacol Unit, Milan, Italy
[3] ASST Fatebenefratelli Sacco Univ Hosp, Dept Infect Dis, Milan, Italy
关键词
WARFARIN;
D O I
10.1097/QAD.0000000000002878
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1327 / 1328
页数:2
相关论文
共 50 条
  • [21] Carbamazepine and clarithromycin:: a clinically relevant drug interaction
    Gelisse, P.
    Hillaire-Buys, D.
    Halaili, E.
    Jean-Pastor, M. -J.
    Vespignan, H.
    Coubes, P.
    Crespel, A.
    [J]. REVUE NEUROLOGIQUE, 2007, 163 (11) : 1096 - 1099
  • [22] The Importance of Clinically Relevant Research When Making Comparisons
    Fisher, Jack
    Brindle, C. Tod
    Porter, Stephen
    [J]. AESTHETIC SURGERY JOURNAL, 2018, 38 (04) : NP76 - NP78
  • [23] WHEN IS A POSITIVE NASAL CHALLENGE TEST CLINICALLY RELEVANT
    REINERT, M
    [J]. RESPIRATION, 1981, 41 (04) : 270 - 275
  • [24] When does oligozoospermia become relevant? Possibilities and limitations of treatment
    Schill, WB
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1997, 260 (1-4) : 496 - 503
  • [25] Effect of Aprepitant on Etoposide Pharmacokinetics in Patients with Testicular Cancer: A Pharmacokinetic Study to Determine the Absence of a Clinically Relevant Interaction
    Strik, Jeffrey
    de Jong, Loek A. W.
    Sijm, Joost
    Desar, Ingrid M. E.
    van Erp, Nielka P.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 (01) : 135 - 138
  • [26] CAN EDUCATIONAL RESEARCH BECOME RELEVANT TO PRACTICE? IF SO, HOW?
    Calvani, Antonio
    [J]. JOURNAL OF EDUCATIONAL CULTURAL AND PSYCHOLOGICAL STUDIES, 2022, (26): : 143 - 162
  • [27] A clinically relevant pharmacokinetic interaction between cyclosporine and imatinib
    Atiq, Ferdows
    Broers, Annoek E. C.
    Andrews, Louise M.
    Doorduijn, Jeanette K.
    Koch, Birgit C. P.
    Van Gelder, Teun
    Versmissen, Jorie
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (06) : 719 - 723
  • [28] No clinically relevant pharmacokinetic interaction between ambrisentan and sildenafil
    Dufton, Christopher
    Gerber, Michael J.
    Yin, Ophelia
    Brandquist, Christine
    Ghofrani, Hossein A.
    [J]. CHEST, 2006, 130 (04) : 254S - 254S
  • [29] Moxifloxacin and warfarin: Additional evidence for a clinically relevant interaction
    Arnold, LM
    Nissen, LR
    Ng, TMH
    [J]. PHARMACOTHERAPY, 2005, 25 (06): : 904 - 907
  • [30] Lack of Clinically Relevant Interaction Between Desloratadine and Erythromycin
    Christopher Banfield
    Thomas Hunt
    Larisa Reyderman
    Paul Statkevich
    Desmond Padhi
    Melton Affrime
    [J]. Clinical Pharmacokinetics, 2002, 41 : 29 - 35